Imunon Inc (IMNN): Next-Year EPS Estimate 43.22%
As of 2026-06-04, Imunon Inc (IMNN) has a next-year EPS growth estimate of 43.22%.
On 2026-05-17, analyst consensus for IMNN's next-year EPS growth shifted from 43.44% to 43.22% — a negative change of 0.22 percentage points. The revised estimate has been sustained across 15 subsequent trading sessions. Current-year growth is projected at 50.88%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 43.22%
- EPS growth this year
- 50.88%
- EPS next quarter (est)
- -$0.99
- Last price
- $2.10
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 43.22% | 50.88% | -$0.99 | $2.10 |
| 2026-06-03 | 43.22% | 50.88% | -$0.99 | $2.10 |
| 2026-06-02 | 43.22% | 50.88% | -$0.99 | $2.14 |
| 2026-06-01 | 43.22% | 50.88% | -$0.99 | $2.15 |
| 2026-05-31 | 43.22% | 50.88% | -$0.99 | $2.18 |
| 2026-05-28 | 43.22% | 50.88% | -$0.99 | $2.30 |
| 2026-05-27 | 43.22% | 50.88% | -$0.99 | $2.30 |
| 2026-05-26 | 43.22% | 50.88% | -$0.99 | $2.20 |
| 2026-05-25 | 43.22% | 50.88% | -$0.99 | $2.20 |
| 2026-05-24 | 43.22% | 50.88% | -$0.99 | $2.20 |
| 2026-05-21 | 43.22% | 50.88% | -$0.99 | $2.15 |
| 2026-05-20 | 43.22% | 50.88% | -$0.99 | $2.13 |
| 2026-05-19 | 43.22% | 50.88% | -$0.99 | $2.23 |
| 2026-05-18 | 43.22% | 50.88% | -$0.99 | $2.26 |
| 2026-05-17 | 43.22% | 50.88% | -$0.99 | $2.49 |
| 2026-05-14 | 43.44% | 51.21% | -$0.92 | $2.55 |
| 2026-05-13 | 43.44% | 51.21% | -$0.92 | $2.58 |
| 2026-05-12 | 44.21% | 49.74% | -$0.94 | $2.70 |
| 2026-05-11 | 44.21% | 49.74% | -$1.22 | $2.73 |
| 2026-05-10 | 44.21% | 49.74% | -$1.22 | $2.72 |
| 2026-05-07 | 44.21% | 49.74% | -$1.22 | $2.73 |
| 2026-05-06 | 44.21% | 49.74% | -$1.22 | $2.71 |
| 2026-05-05 | 44.21% | 49.74% | -$1.22 | $2.77 |
| 2026-05-04 | 44.21% | 49.74% | -$1.22 | $2.80 |
| 2026-05-03 | 44.21% | 49.74% | -$1.22 | $2.80 |
| 2026-04-30 | 44.21% | 49.74% | -$1.22 | $2.83 |
| 2026-04-29 | 44.21% | 49.74% | -$1.22 | $2.68 |
| 2026-04-28 | 44.21% | 49.74% | -$1.22 | $2.75 |
| 2026-04-27 | 44.21% | 49.74% | -$1.22 | $2.80 |
| 2026-04-26 | 44.21% | 49.74% | -$1.22 | $2.79 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Imunon Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Imunon Inc (IMNN) has a next-year EPS growth estimate of 43.22%, based on analyst consensus.
When was the latest EPS estimate revision for IMNN?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 43.44% to 43.22%.
What sector and industry does Imunon Inc belong to?▾
Imunon Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. IMNN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Imunon Inc (IMNN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports